We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
151
Becton Dickinson
BDX
$48.8B
$3.43M 0.06%
13,271
+1,136
+9% +$307K
IDYA icon
152
IDEAYA Biosciences
IDYA
$3.49B
$3.4M 0.06%
126,149
-15,000
-11% -$380K
AZN icon
153
AstraZeneca
AZN
$250B
$3.35M 0.06%
24,771
+8,000
+48% +$1.09M
TTEK icon
154
Tetra Tech
TTEK
$8.89B
$3.34M 0.06%
109,975
+31,000
+39% +$1.01M
GRAB icon
155
Grab
GRAB
$15B
$3.13M 0.06%
+885,000
New +$3.16M
ROKU icon
156
Roku
ROKU
$22.3B
$3.1M 0.06%
43,972
+8,972
+26% +$695K
USAR
157
USA Rare Earth Inc
USAR
$4.26B
$3.06M 0.05%
+300,000
New +$3.05M
PDD icon
158
Pinduoduo
PDD
$129B
$3.04M 0.05%
30,964
-23,675
-43% -$2.04M
EA icon
159
Electronic Arts
EA
$3.01M 0.05%
+25,000
New +$3.15M
APCA
160
DELISTED
AP Acquisition Corp
APCA
$2.99M 0.05%
271,895
APXI
161
DELISTED
APx Acquisition Corp. I Class A Ordinary Share
APXI
$2.98M 0.05%
271,895
CRWD icon
162
CrowdStrike
CRWD
$211B
$2.93M 0.05%
+70,000
New +$2.72M
BZAI
163
Blaize Holdings
BZAI
$138M
$2.87M 0.05%
271,895
SLAM
164
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$2.86M 0.05%
264,972
AXNX
165
DELISTED
Axonics, Inc. Common Stock
AXNX
$2.84M 0.05%
50,676
-3,000
-6% -$169K
NET icon
166
Cloudflare
NET
$101B
$2.84M 0.05%
+45,000
New +$2.88M
UTHR icon
167
United Therapeutics
UTHR
$22.6B
$2.83M 0.05%
12,525
-2,000
-14% -$461K
MRTX
168
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.82M 0.05%
64,698
+5,000
+8% +$179K
IONS icon
169
Ionis Pharmaceuticals
IONS
$9.06B
$2.81M 0.05%
62,059
-10,000
-14% -$413K
PHYT
170
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$2.78M 0.05%
254,990
VSAC
171
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.77M 0.05%
254,212
RARE icon
172
Ultragenyx Pharmaceutical
RARE
$2.54B
$2.74M 0.05%
76,915
+9,567
+14% +$379K
BSX icon
173
Boston Scientific
BSX
$71.4B
$2.71M 0.05%
51,392
+10,000
+24% +$524K
UDR icon
174
UDR
UDR
$12.3B
$2.69M 0.05%
+75,442
New +$3.01M
ABBV icon
175
AbbVie
ABBV
$431B
$2.67M 0.05%
17,900
-23,700
-57% -$3.48M

Similar funds

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.